Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph II Pembrolizumab w/ RT and Adj Pembrolizumab in Pts w/Soft Tissue Sarcoma of the Extremity

Protocol: OSU-17015

Full Title

A Phase II Randomized Controlled Trial of Neoadjuvant Pembrolizumab with Radiotherapy and Adjuvant Pembrolizumab in Patients with High-Risk, Localized Soft Tissue Sarcoma of the Extremity

Sarcoma Soft Tissue Sarcoma